World No Tobacco Day: Unmasking the appeal

	Respiratory Diseases
	The latest respiratory diseases news from News Medical

World No Tobacco Day aims to raise awareness of the significant impact smoking can have on health and economic costs. Costing the global economy more than $1.4 trillion annually, we’re exploring the appeal behind smoking tobacco, the healthcare burden it causes and how CO monitoring can aid a quit smoking attempt.

			Study finds widespread hantavirus exposure among Pacific Northwest rodent populations The Sin Nombre virus – a hantavirus that can cause a deadly respiratory disease in humans – may be more widespread among rodent populations in parts of the Pacific Northwest than previously recognized.

			Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001 Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today announced that its Phase 2 trial for ETD001, the Company's lead candidate for treatment of cystic fibrosis (CF), achieved its primary efficacy outcome.

			Study compares two antibiotics in treating severe hemorrhagic bacterial pneumonia Stenotrophomonas maltophilia (S. maltophilia) is a multidrug-resistant bacterium that can cause severe and life-threatening hemorrhagic pneumonia in individuals with weakened immune systems.

			Study finds pulmonary rehab empowers children with respiratory issues New research presented at the 2026 ATS International Conference shows that pulmonary rehabilitation (PR) significantly improves functioning and quality of life in children with chronic respiratory conditions, regardless of whether lung function itself improves.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026